MEDVi Reviews

MEDVi GLP-1 Review: Is the "Concierge" Telehealth Model Worth It?

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Our rating: 3.5/5

MEDVi positions itself as "concierge-level" GLP-1 telehealth — more clinical depth than budget platforms, at a lower price than premium programs like Calibrate. MEDVi offers genuine value in its bundled coaching model, but the "concierge" label is aspirational, and there are legitimate concerns about the company's maturity and mixed patient reviews.

Editorial Independence Note: Telehealth Ally does not accept payment from providers for placement or ranking. This review is independently researched. See our editorial policy for details.

What does MEDVi offer?

MEDVi provides compounded and brand-name GLP-1 medications through a subscription that bundles medication, physician consultations, and metabolic coaching into a single monthly price.

Feature	Details
Medications	Compounded semaglutide, compounded tirzepatide, brand Wegovy, brand Zepbound
Consultation model	Video visits with board-certified physicians (every 4-6 weeks)
Coaching	Monthly metabolic coaching sessions included
Lab work	Not included (available through partner labs at additional cost)
States	Available in 47 US states
HSA/FSA	Accepted

How much does MEDVi cost per month?

MEDVi charges $199/month for compounded semaglutide and $349/month for compounded tirzepatide — both prices include physician visits and metabolic coaching, with no separate membership fee. MEDVi's pricing structure is all-inclusive for the compounded programs — one price covers physician visits, medication, and coaching. No separate membership fee.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

Program	Monthly Cost	Notes
Compounded semaglutide	$199/mo	All doses, physician visits, coaching included
Compounded tirzepatide	$349/mo	First month may be $279 (promotional); standard $349-$399
Brand Wegovy (insurance)	Insurance-dependent	MEDVi accepts insurance for brand medications
Brand Zepbound (insurance)	Insurance-dependent	Insurance handling available
Lab work	Additional cost	Not included in program fee

How does MEDVi pricing compare to other providers?

Provider	Compounded Semaglutide	Coaching Included?	Video Visits?
Ro	$149/mo	Metabolic coaching (yes)	No
Henry Meds	$119/mo	No	No
Mochi Health	$178/mo all-in ($79 membership + $99 medication)	Dietitian access (yes)	Yes
MEDVi	$199/mo	Metabolic coaching (yes)	Yes (every 4-6 weeks)
Calibrate	$199/mo program + medication separate	Full coaching + labs (yes)	Yes

The honest assessment: At $199/month, MEDVi is $50/month more than Ro and $80/month more than Henry Meds for compounded semaglutide. The premium gets you video physician consultations and metabolic coaching — services that Ro and Henry Meds don't offer. Whether that's worth $50/month depends on how much you value face-to-face clinical interaction.

Compared to Mochi Health (~$178/month all-in with dietitian access), MEDVi costs slightly more but offers physician-led video visits rather than Mochi's broader dietitian + physician model. Compared to Calibrate ($199/month program fee + medication costs separately), MEDVi's bundled pricing is simpler and potentially cheaper depending on medication source.

What do we like about MEDVi?

Bundled pricing transparency. One monthly price covers physician visits, medication, and coaching. No separate membership fees, no hidden costs beyond lab work. This is simpler than Mochi's two-part pricing model.

Video physician consultations every 4-6 weeks. In a market dominated by async questionnaires, regular video visits with a board-certified physician represent meaningfully more clinical depth. Patients can discuss side effects, dosing adjustments, and progress face-to-face.

Metabolic coaching included. Monthly coaching sessions covering nutrition, exercise, and behavioral strategies go beyond pure medication delivery. This is table stakes for premium platforms like Calibrate but rare at MEDVi's price point.

Both compounded and brand options. Patients can start on compounded medications and transition to brand-name through insurance if coverage is available — without changing providers.

What concerns us about MEDVi?

Mixed patient reviews. ConsumerAffairs and other review platforms show genuinely mixed feedback. Some patients report billing issues (unexpected charges, difficulty canceling), inconsistent shipping timelines, and communication gaps. Others report strong results and positive provider experiences. The inconsistency suggests growing pains for a young company.

Company maturity. Founded in 2022, MEDVi is still a young telehealth startup. The "concierge" branding sets high expectations that a company of this size may struggle to consistently deliver. We recommend tempering expectations — this is a well-intentioned mid-tier telehealth service, not a white-glove concierge medicine practice.

Compounding risk. Like all providers offering compounded GLP-1 medications, MEDVi faces the evolving FDA enforcement landscape. The FDA has issued thousands of warning letters to compounding pharmacies and telehealth companies since September 2025. Patients should ask MEDVi directly about their compounding pharmacy partnerships and regulatory standing.

Lab work not included. For a platform positioning itself as clinically comprehensive, the absence of included lab work is a notable gap. Calibrate includes lab panels; MEDVi does not. Metabolic health monitoring without baseline labs is incomplete.

Tirzepatide pricing is high. At $349/month for compounded tirzepatide, MEDVi is more expensive than most competitors. The April 2026 GlobeNewsWire article claiming MEDVi is the "most affordable tirzepatide" warrants scrutiny — the first-month promotional price of $279 is competitive, but the standard ongoing price is not.

What about MEDVi's compounded medications?

MEDVi's compounded medications are the primary draw for cash-pay patients. But the regulatory landscape has shifted significantly:

• Orforglipron is awaiting FDA approval (PDUFA April 10, 2026) at $149/month — would be cheaper than MEDVi's compounded semaglutide and fully FDA-approved
• The FDA continues enforcement against compounding pharmacies, though mass shutdowns have not materialized
• Hims exited compounding entirely in April 2026, signaling the market direction

For patients considering MEDVi's compounded options, the key question is whether the clinical extras (video visits, coaching) justify the $50/month premium over Ro's compounded semaglutide — or whether switching to a $149/month FDA-approved option like oral Wegovy, or waiting for orforglipron (PDUFA April 10, 2026), is the better move. Patients wondering about the cheapest way to get semaglutide online will find Ro or Henry Meds more competitive on price alone.

Who is MEDVi best for?

• Patients who want more clinical support than Ro or Henry Meds but can't afford Calibrate's program fee plus separate medication costs
• Patients who value video consultations — if face-to-face interaction with your prescribing physician matters, MEDVi offers this where most budget competitors don't
• Patients interested in compounded tirzepatide with coaching — few platforms bundle tirzepatide with regular physician visits at this price point

Who should look elsewhere?

• Budget-focused patients — Ro ($149/mo) or Henry Meds ($119/mo) are cheaper for compounded semaglutide
• Patients who want FDA-approved medications only — Consider oral Wegovy ($149-$199/mo), orforglipron ($149/mo announced, PDUFA April 10, 2026), or Hims (brand Wegovy via Novo Nordisk)
• Patients who need comprehensive clinical programs with labs — Calibrate includes lab panels, a year-long curriculum, and obesity medicine specialists
• Risk-averse patients — Given MEDVi's mixed reviews and young company status, patients who prioritize track record should consider established platforms

Is MEDVi worth it?

MEDVi is a legitimate mid-tier GLP-1 telehealth provider that offers more clinical depth than budget platforms at a reasonable price premium. The bundled pricing model is transparent, and the inclusion of video physician visits and metabolic coaching is genuine value.

But the "concierge" positioning oversells the experience. Mixed patient reviews, no included lab work, and the inherent uncertainty of compounded GLP-1 medications all temper our enthusiasm. We rate MEDVi 3.5/5 — a solid option for the right patient, but not a standout in an increasingly competitive market.

If you're choosing between MEDVi and a budget provider, the $50/month premium for video visits and coaching is reasonable if you'll actually use those services. If you're choosing between MEDVi's compounded semaglutide and oral Wegovy at $149/month (or orforglipron once it receives FDA approval), the case for MEDVi is harder to make on medication value alone — though the coaching component may tip the scales. For most patients asking whether MEDVi is worth it, the honest answer is: it depends on whether you'll actually attend those coaching sessions.

Frequently Asked Questions

Is MEDVi legit? Yes. MEDVi is a LegitScript-certified telehealth company operating with licensed physicians. It is a younger company (founded 2022) with mixed reviews — some patients report billing issues and shipping inconsistencies, while others report strong clinical experiences.

How much does MEDVi cost per month? $199/month for compounded semaglutide and $349/month for compounded tirzepatide (first month may be $279 promotional). Both prices include physician visits and metabolic coaching. Lab work is an additional cost.

Does MEDVi take insurance? MEDVi accepts insurance for brand-name GLP-1 medications (Wegovy, Zepbound) but not for compounded medication programs. HSA/FSA cards are accepted.

How do I cancel MEDVi? Contact MEDVi's support team to cancel. Multiple patient reviews mention billing continuing after cancellation requests — confirm in writing and follow up if charges continue.

Is MEDVi's semaglutide FDA-approved? No. MEDVi's compounded semaglutide is not FDA-approved as a finished drug product. The active ingredient is the same as Wegovy, but compounded formulations have not individually undergone FDA review. Brand-name Wegovy and Zepbound (available through MEDVi with insurance) are FDA-approved.

How does MEDVi compare to Ro? Ro charges $149/month for compounded semaglutide with no video visits or coaching. MEDVi charges $199/month but includes video physician consultations and metabolic coaching. The $50/month premium is worth it if you'll use those services; if you just want medication access, Ro is cheaper.

Is MEDVi a good option for getting GLP-1 without insurance? It is an option, though not the cheapest. For cash-pay patients asking how to get GLP-1 without insurance, Ro ($149/mo) and Henry Meds ($119/mo) offer lower prices for semaglutide without coaching or video visits.

Related Content

• MEDVi Provider Profile — Company details and full pricing
• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• Mochi Health Review — Similar mid-tier competitor
• Calibrate Review — Premium program comparison
• MEDVi vs Calibrate — Side-by-side comparison
• GLP-1 Cost & Insurance FAQ — What you'll actually pay

---

This review is for informational purposes only and does not constitute medical advice. MEDVi review based on publicly available pricing, patient reviews, and platform analysis as of April 2026. Pricing and services may change — confirm directly with MEDVi before enrolling. Last updated March 28, 2026.

Data Sources & Methodology

Pricing and protocol data sourced from Medvi's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.